GxP Data-Boundary GCC Operating-Model Director

The mandate

The pharmaceutical group wants its India GCC to own clinical-data pipelines and validated research platforms, but current proposals alternate between unrestricted global engineering and task-level execution behind overseas quality approvals. Data residency, validated state, patient privacy, study blinding and supplier access intersect differently by service. The defined problem is to establish operable boundaries for accountability, data and quality before recruitment accelerates.

The named deliverable is a GxP Data-Boundary GCC Operating Model and Transfer Blueprint. It must classify services and data, map validated responsibilities, allocate parent and India decision rights, define quality independence, access and evidence, supplier boundaries, talent roles, change and incident governance, value measures, transfer gates and two representative service designs.

Four milestones govern six months: by week three, accept the service and regulatory inventory; by week ten, deliver data-flow, validation and authority maps; by week eighteen, test the operating model through change, incident and inspection simulations; and by week twenty-six, submit the blueprint, transfer waves and executive decision paper. Each invoice follows milestone acceptance.

The research officer and quality council will accept the work only when every regulated service has one accountable owner, quality approval remains independent and timely, India access and data handling satisfy approved boundaries, validated changes and incidents can run through the model, source-team exit is measurable, and client leaders can classify a new service without consultant mediation.

The client will provide service inventories, data-flow records, validation plans, quality procedures, privacy classifications, audit findings, supplier contracts, role designs and access to Switzerland and India teams. The consultant will not provide legal advice, validate software, recruit staff, execute transfers, change clinical policy or approve data access; interpretation decisions remain with accountable officers.

Why this is external work

Quality, research, privacy and engineering teams each describe a valid part of the boundary but have not produced one operating model. Potential source owners also influence whether authority leaves Switzerland. External regulated-GCC expertise is needed to make tensions explicit, exercise the model and prevent compliance language from either blocking meaningful ownership or concealing unsafe transfer.

What you will own

• Classify clinical-data and validated-platform services by GxP relevance, data type, study state, criticality and location obligation.
• Map collection, transformation, storage, model use, access, change, support and evidence across parent, India and suppliers.
• Allocate product, engineering, quality, privacy, security, incident and risk decisions with independent assurance boundaries.
• Define India leadership, skills, privileged access, training and succession required for accountable regulated operation.
• Build transfer gates for validation knowledge, change execution, incident command, inspection response and source-team exit.
• Establish value measures across research cycle, data quality, platform reliability, control evidence, talent depth and cost.
• Deliver the operating model, two service blueprints, simulation evidence, transfer sequence and unresolved interpretation register.

Candidate qualifications

• Designed an India GCC operating model for GxP, clinical-data or comparably validated technology services.
• Allocated engineering and product authority while preserving independent quality review and accountable regulated decisions.
• Mapped residency, blinding, privacy, validation and supplier access into executable technical and operating controls.
• Used inspection, change and incident simulations to expose gaps before transferring regulated service ownership.
• Built specialised India leadership and talent requirements around service accountability rather than generic delivery roles.
• Delivered classification and transfer methods that client teams applied independently to new regulated services.

Non-negotiables

• Can complete both India residencies and all Zurich quality-council milestones within six months.
• Will disclose pharmaceutical, CRO, cloud, validation, GCC and systems-integration relationships.
• Brings live GxP technology transfer into India; generic data governance or shared-services design alone is insufficient.
• Accepts client-run regulated scenarios and accountable officer approval as final acceptance conditions.

1. 49 words maximum. Describe a GxP technology decision that an India engineering owner could make without compromising quality independence.
2. 49 words maximum. Which data or validation boundary would you map before approving the first regulated service transfer?
3. 49 words maximum. How would you prove source-team exit without weakening inspection readiness?